Insmed Incorporated
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Insmed Incorporated generated cash of -$536,247,000, which is less than the previous year. Cash used in financing activities reached the amount of $168,439,000 last year. Net change in cash is therefore -$591,662,000.
Cash Flow
| 2014 | -64.41M | -5.34M | 115.08M |
|---|---|---|---|
| 2015 | -100.7M | -3.45M | 227.80M |
| 2016 | -146.70M | -4.2M | 30.67M |
| 2017 | -159.61M | -3.00M | 381.08M |
| 2018 | -257.97M | -14.81M | 386.74M |
| 2019 | -250.64M | -42.26M | 285.27M |
| 2020 | -219.34M | -6.82M | 271.00M |
| 2021 | -363.30M | -64.28M | 612.54M |
| 2022 | -400.43M | -34.58M | 793.27M |
| 2023 | -536.24M | -223.60M | 168.43M |
INSM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.07B | 716.78M | 532.75M | 487.42M | 495.07M | 381.16M | 162.59M | 282.87M | 159.22M | 113.89M |
Operating activities | ||||||||||
Net income | -749.56M | -481.53M | -434.65M | -294.09M | -254.33M | -324.27M | -192.64M | -176.27M | -118.18M | -79.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 10.57M | 10.33M | 14.18M | 14.15M | 10.18M | 4.82M | 2.90M | 2.43M | 1.98M | 1.07M |
Stock-based compensation expense | 74.77M | 57.68M | 46.02M | 36.15M | 28.6M | 0 | 18.07M | 18.03M | 15.59M | 11.32M |
| Deferred income tax benefit | 74.77M | 57.68M | 46.02M | 36.15M | 28.6M | 0 | 18.07M | 18.03M | 15.59M | 11.32M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -11.96M | -6.42M | -8.11M | 2.67M | -13.71M | -5.51M | 0 | 0 | 0 | 0 |
Inventories | -13.61M | -1.71M | -17.45M | -21.18M | -21.28M | -7.03M | 0 | 0 | 0 | 0 |
Accounts payable | 15.15M | 50.01M | -7.57M | 29.82M | -4.96M | 3.87M | 3.60M | 2.76M | -1.78M | 3.31M |
Cash generated by operating activities | -536.24M | -400.43M | -363.30M | -219.34M | -250.64M | -257.97M | -159.61M | -146.70M | -100.7M | -64.41M |
Investing activities | ||||||||||
Purchases Of Investments | -588.73M | -99.70M | -50.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -13.28M | -9.87M | -7.28M | -6.82M | -42.26M | -14.81M | -3.00M | -4.2M | -3.45M | -5.35M |
Acquisitions Net | 0 | 24.70M | -6.70M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -223.60M | -34.58M | -64.28M | -6.82M | -42.26M | -14.81M | -3.00M | -4.2M | -3.45M | -5.34M |
Financing activities | ||||||||||
Common Stock Issued | 152.47M | 292.15M | 269.88M | 245.86M | 261.07M | 8.81M | 377.65M | 1.08M | 222.94M | 109.01M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.21M | 349.39M | -225M | -936K | 0 | -57.83M | 0 | -29.58M | 0 | -64K |
Cash used in financing activities | 168.43M | 793.27M | 612.54M | 271.00M | 285.27M | 386.74M | 381.08M | 30.67M | 227.80M | 115.08M |
Net Change In Cash | -591.66M | 357.25M | 184.02M | 45.32M | -7.64M | 113.90M | 218.57M | -120.28M | 123.65M | 45.33M |
Cash at end of period | 482.37M | 1.07B | 716.78M | 532.75M | 487.42M | 495.07M | 381.16M | 162.59M | 282.87M | 159.22M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |